The Journal of Neuroscience, February 14, 2007, 27(7):1702-1711; doi:10.1523/JNEUROSCI.5055-06.2007
Previous Article | Next Article 
Cellular/Molecular
Identification of CRMP4 as a Convergent Regulator of Axon Outgrowth Inhibition
Yazan Z. Alabed,
Madeline Pool,
Stephan Ong Tone, and
Alyson E. Fournier
Department of Neurology and Neurosurgery, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4
Correspondence should be addressed to Dr. Alyson E. Fournier, Montreal Neurological Institute, BT-109, 3801 Rue University, Montreal, Quebec, Canada H3A 2B4. Email: alyson.fournier{at}mcgill.ca
Myelin-associated inhibitors (MAIs) and chondroitin sulfate proteoglycans (CSPGs) contribute to failed regeneration after neuronal injury. MAIs and CSPGs stimulate intracellular signals including the activation of RhoA and Rho kinase to block axonal extension through targeted modifications to the cytoskeleton. RhoA and ROCK are promising targets for therapeutic intervention to promote CNS repair; however, their ubiquitous expression will limit the specificity of drugs targeted to these molecules. We have identified the cytosolic phosphoprotein CRMP4b (collapsin-response mediator protein 4b) as a protein that physically and functionally interacts with RhoA to mediate neurite outgrowth inhibition. Short interfering RNA-mediated knockdown of CRMP4 promotes neurite outgrowth on myelin substrates, indicating a critical role for CRMP4 in neurite outgrowth inhibition. Disruption of CRMP4bRhoA binding with a competitive inhibitor attenuates neurite outgrowth inhibition on myelin and aggrecan substrates. Stimulation of neuronal growth cones with Nogo leads to colocalization of CRMP4b and RhoA at discrete regions within the actin-rich central and peripheral domains of the growth cone, indicative of a potential function in cytoskeletal rearrangements during neurite outgrowth inhibition. Together, these data indicate that a RhoACRMP4b complex forms in response to inhibitory challenges in the growth cone environment and regulates cytoskeletal dynamics at distinct sites necessary for axon outgrowth inhibition. Competitive inhibition of CRMP4bRhoA binding suggests a novel, highly specific therapeutic avenue for promoting regeneration after CNS injury.
Key words: Nogo; CRMP; TUC; glial scar; CNS regeneration; myelin inhibition; Rho GTPase
Received July 24, 2006;
revised Jan. 9, 2007;
accepted Jan. 10, 2007.
Correspondence should be addressed to Dr. Alyson E. Fournier, Montreal Neurological Institute, BT-109, 3801 Rue University, Montreal, Quebec, Canada H3A 2B4. Email: alyson.fournier{at}mcgill.ca
This article has been cited by other articles:

|
 |

|
 |
 
A. M. Fontainhas and E. Townes-Anderson
RhoA and Its Role in Synaptic Structural Plasticity of Isolated Salamander Photoreceptors
Invest. Ophthalmol. Vis. Sci.,
September 1, 2008;
49(9):
4177 - 4187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Johnston, W. W. Wright, P. DiCandeloro, E. Wilson, G. S. Kopf, and S. A. Jelinsky
Stage-specific gene expression is a fundamental characteristic of rat spermatogenic cells and Sertoli cells
PNAS,
June 17, 2008;
105(24):
8315 - 8320.
[Abstract]
[Full Text]
[PDF]
|
 |
|